Your browser doesn't support javascript.
loading
Targeting the PI3K/Akt/mTOR signaling pathway by pterostilbene attenuates mantle cell lymphoma progression.
Yu, Dandan; Zhang, Yong; Chen, Gege; Xie, Yongsheng; Xu, Zhijian; Chang, Shuaikang; Hu, Liangning; Li, Bo; Bu, Wenxuan; Wang, Yingcong; Xiao, Wenqin; Sun, Xi; Chang, Gaomei; Gao, Lu; Qiang, Sujing; Wu, Xiaosong; Zhu, Weiliang; Shi, Jumei.
Afiliación
  • Yu D; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Zhang Y; CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Chen G; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Xie Y; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Xu Z; CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Chang S; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Hu L; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Li B; CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Bu W; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Wang Y; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Xiao W; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Sun X; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Chang G; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Gao L; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Qiang S; Tongji University Cancer Center, Tongji University, Shanghai, China.
  • Wu X; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
  • Zhu W; CAS Key Laboratory of Receptor Research, Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
  • Shi J; Department of Hematology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Acta Biochim Biophys Sin (Shanghai) ; 50(8): 782-792, 2018 Aug 01.
Article en En | MEDLINE | ID: mdl-29961897
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Estilbenos / Transducción de Señal / Fosfatidilinositol 3-Quinasas / Linfoma de Células del Manto / Proteínas Proto-Oncogénicas c-akt / Serina-Treonina Quinasas TOR Límite: Animals / Female / Humans Idioma: En Revista: Acta Biochim Biophys Sin (Shanghai) Asunto de la revista: BIOFISICA / BIOQUIMICA Año: 2018 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Estilbenos / Transducción de Señal / Fosfatidilinositol 3-Quinasas / Linfoma de Células del Manto / Proteínas Proto-Oncogénicas c-akt / Serina-Treonina Quinasas TOR Límite: Animals / Female / Humans Idioma: En Revista: Acta Biochim Biophys Sin (Shanghai) Asunto de la revista: BIOFISICA / BIOQUIMICA Año: 2018 Tipo del documento: Article País de afiliación: China